logo
    Abstract:
    Abstract Background To evaluate the cytokine profile in gingival crevicular fluid (GCF) and serum of pediatric inflammatory bowel disease (IBD) patients and determine the cluster patterns of cytokines. Methods Fifty IBD patients and 21 systemically healthy children were enrolled in the study. The GCF samples were collected from the participants during periodontal examination and periodontal indices were recorded. Based on activity indexes and response to conventional treatment, patients with IBD were further categorized into subgroups as: remission, active disease, and treatment‐resistant. Serum samples were obtained from IBD patients to determine serum levels of cytokines. The levels of pro‐ (interleukin (IL)‐1β, IL‐12, IL‐21, IL‐22, IL‐23, IL‐17A, IL‐17F) and anti‐inflammatory (IL‐4, IL‐10) cytokines in serum and GCF were measured using Enzyme‐linked Immunosorbent Assay (ELISA) kits. Results Among 50 IBD patients, 58% were in remission, 20% had active disease, and 22% were defined as treatment‐resistant. The severity of gingival inflammation measured by the criteria of Löe had increasing trends in IBD patients with active disease and treatment resistance. GCF IL‐1β level was lower and GCF IL‐4 and GCF IL‐23 levels were higher in IBD patients compared to healthy controls. In the active disease group, more cytokine clusters occurred compared to the control group and other IBD subgroups, as explained by increased cytokine‐cytokine interactions. Conclusions Considering the increased complexity of cytokine interactions and the increased severity of gingival inflammation in patients with active disease, it can be concluded that disease activity might have an impact on gingival inflammation in pediatric patients with IBD.
    Inflammatory Bowel Disease (Ulcerative Colitis, Crohn's Disease): Early History, Current Concepts, and 21st Century Directions Joseph B. Kirsner Epidemiology of Inflammatory Bowel Disease Charles N. Bernstein and James F. Blanchard Etiology and Pathogenesis of Inflammatory Bowel Disease James J. Farrell and Bruce E. Sands Genetics of Inflammatory Bowel Disease Judy Cho Presentation and Diagnosis of Inflammatory Bowel Disease Themistocles Dassopoulos and Stephen Hanauer Radiological Findings in Inflammatory Bowel Disease Peter M. MacEneaney and Arunas E. Gasparaitis Inflammatory Bowel Disease Markers Marla C. Dubinsky and Stephan R. Targan Medical Therapy of Inflammatory Bowel Disease Todd E. H. Hecht, Chinyu G. Su, and Gary R. Lichtenstein Surgical Management of Inflammatory Bowel Disease Roger D. Hurst Ostomy Care Janice C. Colwell Inflammatory Bowel Disease in Children and Adolescents Ranjana Gokhale and Barbara S. Kirschner Nutritional/Metabolic Issues in the Management of Inflammatory Bowel Disease Jeanette Newton Keith and Michael Sitrin Extraintestinal Manifestations of Inflammatory Bowel Disease Elena Ricart and William J. Sandborn Cancer in Inflammatory Bowel Disease William M. Bauer and Bret A. Lashner Gender-Specific Issues in Inflammatory Bowel Disease Sunanda V. Kane Economics of Inflammatory Bowel Disease Russell D. Cohen Pathologic Features of Inflammatory Bowel Disease John Hart Index
    Citations (17)
    Topics covered in this reference manual on inflammatory bowel disease include epidemiology, disease definition, extraintestinal manifestations of inflammatory bowel disease, indications for surgery in inflammatory bowel disease, and surgical therapy for inflammatory bowel disease. It includes line drawings, photographs, tables, algorithms, and bulleted text with key facts.
    Citations (10)
    Inflammatory Bowel Diseases
    Crohn disease
    Aims Colonoscopy is of utmost importance in the management of inflammatory bowel disease(IBD). Most studies on inadequate bowel preparation(IBP) have not specifically evaluated the impact of IBD on the quality of bowel preparation. We aimed to identify disease and non-disease related factors for IBP in patients with IBD submitted to colonoscopy.
    Inflammatory Bowel Diseases
    Bowel preparation
    Citations (0)